Please assess the completion status of the following clinical trial:

Trial Title: Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing both FDG PET/CT scan and RNV within two weeks interval, whether for initial staging, restaging or to evaluate response to therapy.~* Patients who would consent to an additional 10-15 minutes acquisition of the gated images after completion of their FDG PET/CT study with the additional radiation exposure.~* Patients with regular heart rate.~Exclusion Criteria:~* Blood glucose level above 200 mg/dL.~* Irregular heart rate.~* An interval of less than 1 day between the FDG PET/CT scan and RNV.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PET/CT scan + NM cardiac scan (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).